Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Oct;22(4):389–394. doi: 10.1111/j.1365-2125.1986.tb02907.x

Comparison of levocabastine, a new selective H1-receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen.

M Kolly, A Pécoud
PMCID: PMC1401150  PMID: 2876723

Abstract

The effect of intranasal administration of levocabastine, a new selective H1-receptor antagonist, was investigated in a nasal provocation test (NPT) performed with allergens. The NPT allowed a quantitative estimation of the nasal allergic threshold (concentration of allergen necessary to trigger the reaction). In addition, the intensity of the three major rhinitis symptoms (obstruction, rhinorrhea and sneezing) was determined. Twelve adult patients, allergic to grass pollen, underwent a first NPT without pretreatment ('initial NPT'); the NPT was then repeated after the single intranasal administration of either placebo, 8 mg disodium cromoglycate (DSCG) or 0.2 mg levocabastine in a double-blind random order. The NPTs gave reproducible results since both the threshold and symptom intensities were similar in the initial NPT and in the NPT performed after placebo. The reaction threshold increased in 8/12 patients after DSCG (0.05 less than P less than 0.1) and in 9/12 patients after levocabastine (P less than 0.05). Levocabastine clearly inhibited rhinorrhea (P less than 0.001) and sneezing (P less than 0.02) but did not influence the nasal obstruction. DSCG inhibited rhinorrhea only (P less than 0.01). The intranasal administration of levocabastine might be useful in the treatment of allergic rhinitis.

Full text

PDF
389

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borum P., Grønborg H., Brofeldt S., Mygind N. Nasal reactivity in rhinitis. Eur J Respir Dis Suppl. 1983;128(Pt 1):65–71. [PubMed] [Google Scholar]
  2. Connell J. T. A novel method to assess antihistamine and decongestant efficacy. Ann Allergy. 1979 May;42(5):278–285. [PubMed] [Google Scholar]
  3. Connell J. T. Quantitative intranasal pollen challenge. II. Effect of daily pollen challenge, environmental pollen exposure, and placebo challenge on the nasal membrane. J Allergy. 1968 Mar;41(3):123–139. doi: 10.1016/0021-8707(68)90053-1. [DOI] [PubMed] [Google Scholar]
  4. Hasegawa M., Saito Y., Watanabe K. The effect of sodium cromoglycate on the antigen-induced nasal reaction in allergic rhinitis as measured by rhinomanometry and symptomatology. Clin Allergy. 1976 Jul;6(4):359–363. doi: 10.1111/j.1365-2222.1976.tb01916.x. [DOI] [PubMed] [Google Scholar]
  5. Howarth P. H., Holgate S. T. Comparative trial of two non-sedative H1 antihistamines, terfenadine and astemizole, for hay fever. Thorax. 1984 Sep;39(9):668–672. doi: 10.1136/thx.39.9.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Mygind N., Johnsen N. J., Thomsen J. Intranasal allergen challenge during corticosteroid treatment. Clin Allergy. 1977 Jan;7(1):69–74. doi: 10.1111/j.1365-2222.1977.tb01426.x. [DOI] [PubMed] [Google Scholar]
  7. Mygind N. Mediators of nasal allergy. J Allergy Clin Immunol. 1982 Sep;70(3):149–159. doi: 10.1016/0091-6749(82)90036-7. [DOI] [PubMed] [Google Scholar]
  8. Pelikan Z., de Vries K. Effects of some drugs applied topically to the nasal mucosa before nasal provocation tests with allergen. Acta Allergol. 1974 Oct;29(5):337–353. doi: 10.1111/j.1398-9995.1974.tb01470.x. [DOI] [PubMed] [Google Scholar]
  9. Phillips M. J., Ollier S., Davies R. J. Use of anterior rhinometry in nasal provocation challenges with allergen and evaluation of the effects of ketotifen, clemastine and sodium cromoglycate on these responses. Respiration. 1980;39 (Suppl 1):26–31. doi: 10.1159/000195035. [DOI] [PubMed] [Google Scholar]
  10. Pipkorn U., Bende M., Hedner J., Hedner T. A double-blind evaluation of topical levocabastine, a new specific H1 antagonist in patients with allergic conjunctivitis. Allergy. 1985 Oct;40(7):491–496. doi: 10.1111/j.1398-9995.1985.tb00255.x. [DOI] [PubMed] [Google Scholar]
  11. Secher C., Brofeldt S., Mygind N. Intranasal verapamil in allergen-induced rhinitis. Allergy. 1983 Nov;38(8):565–570. doi: 10.1111/j.1398-9995.1983.tb04141.x. [DOI] [PubMed] [Google Scholar]
  12. Secher C., Kirkegaard J., Borum P., Maansson A., Osterhammel P., Mygind N. Significance of H1 and H2 receptors in the human nose: rationale for topical use of combined antihistamine preparations. J Allergy Clin Immunol. 1982 Sep;70(3):211–218. doi: 10.1016/0091-6749(82)90044-6. [DOI] [PubMed] [Google Scholar]
  13. Wihl J. A. Methods for assessing nasal reactivity. Eur J Respir Dis Suppl. 1983;128(Pt 1):175–180. [PubMed] [Google Scholar]
  14. Youlten L. J. Nasal airway patency measurement in the assessment of rhinitis therapy. Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M. 1983;(78):111–113. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES